February 25, 2022
Idorsia’s QUVIVIQ (daridorexant) Recommended for Approval in Europe as a New Treatment for Adults with Insomnia Disorder
Idorsia Ltd has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European…